← Back to catalogue

xTAG® Cystic Fibrosis Mutation Detection Kit

FDA UDI

Class II (US FDA UDI)

by Luminex Molecular Diagnostics, Inc.

Identity

Trade Name
xTAG® Cystic Fibrosis Mutation Detection Kit FDA UDI
Generic Name
Cystic fibrosis IVD, kit, multiplex FDA UDI
Device Name
The xTAG® Cystic Fibrosis Kit is a device used to simultaneously detect and identify a panel of mutations and variants in the cystic fibrosis transmembrane conductance regulator (CFTR) gene in human blood specimens FDA UDI
Model / Reference
I006C0068 FDA UDI
Description
The xTAG® Cystic Fibrosis Kit is a device used to simultaneously detect and identify a panel of mutations and variants in the cystic fibrosis transmembrane conductance regulator (CFTR) gene in human blood specimens FDA UDI

Identifiers

Catalog Number
I006C0068 FDA UDI
Primary DI / UDI-DI
00840487100455 FDA UDI
FDA Product Code
NUA FDA UDI
GMDN Term
Cystic fibrosis IVD, kit, multiplex FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.5900 FDA UDI
Commercial Distribution
Not in Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

xTAG® Cystic Fibrosis Mutation Detection Kit by Luminex Molecular Diagnostics, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 5b25ecf7-4ee2-4a75-9151-29cd80aad865 37 fields · synced Jun 1, 2026